A rating of 82 puts Mirati Therapeutics Inc (MRTX) near the top of the Biotechnology industry according to InvestorsObserver. Mirati Therapeutics Inc's score of 82 means it scores higher than 82% of stocks in the industry. Mirati Therapeutics Inc also received an overall rating of 64, putting it above 64% of all stocks. Biotechnology is ranked 35 out of the 148 industries.<\/p>\n
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks.<\/p>\n
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.<\/p>\n
Mirati Therapeutics Inc (MRTX) stock is lower by -0.6% while the S&P 500 is up 0.34% as of 11:44 AM on Wednesday, Dec 30. MRTX is down -$1.32 from the previous closing price of $220.94 on volume of 154,477 shares. Over the past year the S&P 500 has gained 15.75% while MRTX is up 70.43%. MRTX lost -$7.70 per share the over the last 12 months. <\/p>\n
Click Here to get the full Stock Score Report on Mirati Therapeutics Inc (MRTX) Stock.<\/p>\n
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.<\/p>\n
You May Also Like<\/p>\n
<\/p>\n
Read the rest here: A rating of 82 puts Mirati Therapeutics Inc (MRTX) near the top of the Biotechnology industry according to InvestorsObserver. Mirati Therapeutics Inc's score of 82 means it scores higher than 82% of stocks in the industry Continue reading
\nIs Mirati Therapeutics Inc (MRTX) the Top Pick in the Biotechnology Industry? - InvestorsObserver<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"